| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Review Article |
Department of Virology, Room 333, The Wright–Fleming Institute, Faculty of Medicine, Imperial College of Science, Technology & Medicine, St Mary’s Campus, Norfolk Place, London W2 1PG, UK1
Author for correspondence: Geoffrey L. Smith. Fax +44 207 594 3973. e-mail glsmith{at}ic.ac.uk
Vaccinia virus produces four different types of virion from each infected cell called intracellular mature virus (IMV), intracellular enveloped virus (IEV), cell-associated enveloped virus (CEV) and extracellular enveloped virus (EEV). These virions have different abundance, structure, location and roles in the virus life-cycle. Here, the formation and function of these virions are considered with emphasis on the EEV form and its precursors, IEV and CEV. IMV is the most abundant form of virus and is retained in cells until lysis; it is a robust, stable virion and is well suited to transmit infection between hosts. IEV is formed by wrapping of IMV with intracellular membranes, and is an intermediate between IMV and CEV/EEV that enables efficient virus dissemination to the cell surface on microtubules. CEV induces the formation of actin tails that drive CEV particles away from the cell and is important for cell-to-cell spread. Lastly, EEV mediates the long-range dissemination of virus in cell culture and, probably, in vivo. Seven virus-encoded proteins have been identified that are components of IEV, and five of them are present in CEV or EEV. The roles of these proteins in virus morphogenesis and dissemination, and as targets for neutralizing antibody are reviewed. The production of several different virus particles in the VV replication cycle represents a coordinated strategy to exploit cell biology to promote virus spread and to aid virus evasion of antibody and complement.
This article has been cited by other articles:
|
|
 |
|
  K. L. Roberts, A. Breiman, G. C. Carter, H. A. Ewles, M. Hollinshead, M. Law, and G. L. Smith Acidic residues in the membrane-proximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycan-mediated disruption of the extracellular enveloped virus outer membrane J. Gen. Virol., July 1, 2009; 90(7): 1582 - 1591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Huggins, A. Goff, L. Hensley, E. Mucker, J. Shamblin, C. Wlazlowski, W. Johnson, J. Chapman, T. Larsen, N. Twenhafel, et al. Nonhuman Primates Are Protected from Smallpox Virus or Monkeypox Virus Challenges by the Antiviral Drug ST-246 Antimicrob. Agents Chemother., June 1, 2009; 53(6): 2620 - 2625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. A. Olson, K. L. Karem, S. K. Smith, C. M. Hughes, and I. K. Damon Smallpox virus plaque phenotypes: genetic, geographical and case fatality relationships J. Gen. Virol., April 1, 2009; 90(4): 792 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Tan, N. Ueda, A. A. Mercer, and S. B. Fleming Investigation of orf virus structure and morphogenesis using recombinants expressing FLAG-tagged envelope structural proteins: evidence for wrapped virus particles and egress from infected cells J. Gen. Virol., March 1, 2009; 90(3): 614 - 625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Teale, S. Campbell, N. Van Buuren, W. C. Magee, K. Watmough, B. Couturier, R. Shipclark, and M. Barry Orthopoxviruses Require a Functional Ubiquitin-Proteasome System for Productive Replication J. Virol., March 1, 2009; 83(5): 2099 - 2108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. R. Wagenaar and B. Moss Expression of the A56 and K2 Proteins Is Sufficient To Inhibit Vaccinia Virus Entry and Cell Fusion J. Virol., February 15, 2009; 83(4): 1546 - 1554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Johnston and B. M. Ward Vaccinia Virus Protein F12 Associates with Intracellular Enveloped Virions through an Interaction with A36 J. Virol., February 15, 2009; 83(4): 1708 - 1717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R.-E.-I. Benhnia, M. M. McCausland, J. Moyron, J. Laudenslager, S. Granger, S. Rickert, L. Koriazova, R. Kubo, S. Kato, and S. Crotty Vaccinia Virus Extracellular Enveloped Virion Neutralization In Vitro and Protection In Vivo Depend on Complement J. Virol., February 1, 2009; 83(3): 1201 - 1215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Midgley, M. M. Putz, J. N. Weber, and G. L. Smith Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax J. Gen. Virol., December 1, 2008; 89(12): 2992 - 2997. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Nichols, E. Stanitsa, B. Unger, and P. Traktman The Vaccinia Virus Gene I2L Encodes a Membrane Protein with an Essential Role in Virion Entry J. Virol., October 15, 2008; 82(20): 10247 - 10261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Fahy, R. H. Clark, E. F. Glyde, and G. L. Smith Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence J. Gen. Virol., October 1, 2008; 89(10): 2377 - 2387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Bisht, A. S. Weisberg, and B. Moss Vaccinia Virus L1 Protein Is Required for Cell Entry and Membrane Fusion J. Virol., September 1, 2008; 82(17): 8687 - 8694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. N. Fogg, J. L. Americo, P. L. Earl, W. Resch, L. Aldaz-Carroll, R. J. Eisenberg, G. H. Cohen, and B. Moss Disparity between Levels of In Vitro Neutralization of Vaccinia Virus by Antibody to the A27 Protein and Protection of Mice against Intranasal Challenge J. Virol., August 15, 2008; 82(16): 8022 - 8029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Kaufman, J. Goudsmit, L. Holterman, B. A. Ewald, M. Denholtz, C. Devoy, A. Giri, L. E. Grandpre, J.-M. Heraud, G. Franchini, et al. Differential Antigen Requirements for Protection against Systemic and Intranasal Vaccinia Virus Challenges in Mice J. Virol., July 15, 2008; 82(14): 6829 - 6837. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. E. Nelson, T. R. Wagenaar, and B. Moss A Conserved Sequence within the H2 Subunit of the Vaccinia Virus Entry/Fusion Complex Is Important for Interaction with the A28 Subunit and Infectivity J. Virol., July 1, 2008; 82(13): 6244 - 6250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Girgis, B. C. DeHaven, X. Fan, K. M. Viner, M. Shamim, and S. N. Isaacs Cell Surface Expression of the Vaccinia Virus Complement Control Protein Is Mediated by Interaction with the Viral A56 Protein and Protects Infected Cells from Complement Attack J. Virol., May 1, 2008; 82(9): 4205 - 4214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.-H. Xu, M. Cohen, Y. Tang, E. Lazear, J. C. Whitbeck, R. J. Eisenberg, G. H. Cohen, and L. J. Sigal The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination J. Exp. Med., April 14, 2008; 205(4): 981 - 992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Berhanu, R. L. Wilson, D. L. Kirkwood-Watts, D. S. King, T. K. Warren, S. A. Lund, L. L. Brown, A. K. Krupkin, E. VanderMay, W. Weimers, et al. Vaccination of BALB/c Mice with Escherichia coli-Expressed Vaccinia Virus Proteins A27L, B5R, and D8L Protects Mice from Lethal Vaccinia Virus Challenge J. Virol., April 1, 2008; 82(7): 3517 - 3529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R.-E.-I. Benhnia, M. M. McCausland, H.-P. Su, K. Singh, J. Hoffmann, D. H. Davies, P. L. Felgner, S. Head, A. Sette, D. N. Garboczi, et al. Redundancy and Plasticity of Neutralizing Antibody Responses Are Cornerstone Attributes of the Human Immune Response to the Smallpox Vaccine J. Virol., April 1, 2008; 82(7): 3751 - 3768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Perdiguero, M. M. Lorenzo, and R. Blasco Vaccinia Virus A34 Glycoprotein Determines the Protein Composition of the Extracellular Virus Envelope J. Virol., March 1, 2008; 82(5): 2150 - 2160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-K. Hyun, F. Coulibaly, A. P. Turner, E. N. Baker, A. A. Mercer, and A. K. Mitra The Structure of a Putative Scaffolding Protein of Immature Poxvirus Particles as Determined by Electron Microscopy Suggests Similarity with Capsid Proteins of Large Icosahedral DNA Viruses J. Virol., October 15, 2007; 81(20): 11075 - 11083. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. D. Vermeer, J. McHugh, T. Rokhlina, D. W. Vermeer, J. Zabner, and M. J. Welsh Vaccinia Virus Entry, Exit, and Interaction with Differentiated Human Airway Epithelia J. Virol., September 15, 2007; 81(18): 9891 - 9899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Aldaz-Carroll, Y. Xiao, J. C. Whitbeck, M. P. de Leon, H. Lou, M. Kim, J. Yu, E. L. Reinherz, S. N. Isaacs, R. J. Eisenberg, et al. Major Neutralizing Sites on Vaccinia Virus Glycoprotein B5 Are Exposed Differently on Variola Virus Ortholog B6 J. Virol., August 1, 2007; 81(15): 8131 - 8139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Garcia, C. A. Meseda, A. E. Mayer, A. Kumar, M. Merchlinsky, and J. P. Weir Characterization and Use of Mammalian-Expressed Vaccinia Virus Extracellular Membrane Proteins for Quantification of the Humoral Immune Response to Smallpox Vaccines Clin. Vaccine Immunol., August 1, 2007; 14(8): 1032 - 1044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Honeychurch, G. Yang, R. Jordan, and D. E. Hruby The Vaccinia Virus F13L YPPL Motif Is Required for Efficient Release of Extracellular Enveloped Virus J. Virol., July 1, 2007; 81(13): 7310 - 7315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. R. Wagenaar and B. Moss Association of Vaccinia Virus Fusion Regulatory Proteins with the Multicomponent Entry/Fusion Complex J. Virol., June 15, 2007; 81(12): 6286 - 6293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Husain, A. S. Weisberg, and B. Moss Sequence-Independent Targeting of Transmembrane Proteins Synthesized within Vaccinia Virus Factories to Nascent Viral Membranes J. Virol., March 15, 2007; 81(6): 2646 - 2655. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Orynbayeva, S. Kolusheva, N. Groysman, N. Gavrielov, L. Lobel, and R. Jelinek Vaccinia Virus Interactions with the Cell Membrane Studied by New Chromatic Vesicle and Cell Sensor Assays J. Virol., February 1, 2007; 81(3): 1140 - 1147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Husain, A. S. Weisberg, and B. Moss Existence of an operative pathway from the endoplasmic reticulum to the immature poxvirus membrane PNAS, December 19, 2006; 103(51): 19506 - 19511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ojeda, A. Domi, and B. Moss Vaccinia Virus G9 Protein Is an Essential Component of the Poxvirus Entry-Fusion Complex J. Virol., October 1, 2006; 80(19): 9822 - 9830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Perdiguero and R. Blasco Interaction between Vaccinia Virus Extracellular Virus Envelope A33 and B5 Glycoproteins. J. Virol., September 1, 2006; 80(17): 8763 - 8777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Townsley, A. S. Weisberg, T. R. Wagenaar, and B. Moss Vaccinia Virus Entry into Cells via a Low-pH-Dependent Endosomal Pathway. J. Virol., September 1, 2006; 80(18): 8899 - 8908. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Rahbar, T. T. Murooka, A. A. Hinek, C. L. Galligan, A. Sassano, C. Yu, K. Srivastava, L. C. Platanias, and E. N. Fish Vaccinia Virus Activation of CCR5 Invokes Tyrosine Phosphorylation Signaling Events That Support Virus Replication J. Virol., July 15, 2006; 80(14): 7245 - 7259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A.-J. Chen, N. Jacobs, and G. L. Smith Vaccinia virus strain Western Reserve protein B14 is an intracellular virulence factor J. Gen. Virol., June 1, 2006; 87(6): 1451 - 1458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Saijo, Y. Ami, Y. Suzaki, N. Nagata, N. Iwata, H. Hasegawa, M. Ogata, S. Fukushi, T. Mizutani, T. Sata, et al. LC16m8, a Highly Attenuated Vaccinia Virus Vaccine Lacking Expression of the Membrane Protein B5R, Protects Monkeys from Monkeypox. J. Virol., June 1, 2006; 80(11): 5179 - 5188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Najera, C. E. Gomez, E. Domingo-Gil, M. M. Gherardi, and M. Esteban Cellular and Biochemical Differences between Two Attenuated Poxvirus Vaccine Candidates (MVA and NYVAC) and Role of the C7L Gene. J. Virol., June 1, 2006; 80(12): 6033 - 6047. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Munter, M. Way, and F. Frischknecht Signaling During Pathogen Infection Sci. Signal., May 16, 2006; 2006(335): re5 - re5. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Law, G. C. Carter, K. L. Roberts, M. Hollinshead, and G. L. Smith From the Cover: Ligand-induced and nonfusogenic dissolution of a viral membrane PNAS, April 11, 2006; 103(15): 5989 - 5994. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Najarro, C. Gubser, M. Hollinshead, J. Fox, J. Pease, and G. L. Smith Yaba-like disease virus chemokine receptor 7L, a CCR8 orthologue. J. Gen. Virol., April 1, 2006; 87(Pt 4): 809 - 816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kolegraff, P. Bostik, and A. A. Ansari Characterization and role of lentivirus-associated host proteins. Experimental Biology and Medicine, March 1, 2006; 231(3): 252 - 263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. G. Senkevich, S. Ojeda, A. Townsley, G. E. Nelson, and B. Moss Poxvirus multiprotein entry-fusion complex PNAS, December 20, 2005; 102(51): 18572 - 18577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Putz, I. Alberini, C. M. Midgley, I. Manini, E. Montomoli, and G. L. Smith Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy J. Gen. Virol., November 1, 2005; 86(11): 2955 - 2960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Herrero-Martinez, K. L. Roberts, M. Hollinshead, and G. L. Smith Vaccinia virus intracellular enveloped virions move to the cell periphery on microtubules in the absence of the A36R protein J. Gen. Virol., November 1, 2005; 86(11): 2961 - 2968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lustig, C. Fogg, J. C. Whitbeck, R. J. Eisenberg, G. H. Cohen, and B. Moss Combinations of Polyclonal or Monoclonal Antibodies to Proteins of the Outer Membranes of the Two Infectious Forms of Vaccinia Virus Protect Mice against a Lethal Respiratory Challenge J. Virol., November 1, 2005; 79(21): 13454 - 13462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Yang, D. C. Pevear, M. H. Davies, M. S. Collett, T. Bailey, S. Rippen, L. Barone, C. Burns, G. Rhodes, S. Tohan, et al. An Orally Bioavailable Antipoxvirus Compound (ST-246) Inhibits Extracellular Virus Formation and Protects Mice from Lethal Orthopoxvirus Challenge J. Virol., October 15, 2005; 79(20): 13139 - 13149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Davies, M. M. McCausland, C. Valdez, D. Huynh, J. E. Hernandez, Y. Mu, S. Hirst, L. Villarreal, P. L. Felgner, and S. Crotty Vaccinia Virus H3L Envelope Protein Is a Major Target of Neutralizing Antibodies in Humans and Elicits Protection against Lethal Challenge in Mice J. Virol., September 15, 2005; 79(18): 11724 - 11733. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Morikawa, T. Sakiyama, H. Hasegawa, M. Saijo, A. Maeda, I. Kurane, G. Maeno, J. Kimura, C. Hirama, T. Yoshida, et al. An Attenuated LC16m8 Smallpox Vaccine: Analysis of Full-Genome Sequence and Induction of Immune Protection J. Virol., September 15, 2005; 79(18): 11873 - 11891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Chahroudi, R. Chavan, N. Koyzr, E. K. Waller, G. Silvestri, and M. B. Feinberg Vaccinia Virus Tropism for Primary Hematolymphoid Cells Is Determined by Restricted Expression of a Unique Virus Receptor J. Virol., August 15, 2005; 79(16): 10397 - 10407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Townsley, T. G. Senkevich, and B. Moss Vaccinia Virus A21 Virion Membrane Protein Is Required for Cell Entry and Fusion J. Virol., August 1, 2005; 79(15): 9458 - 9469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Resch, A. S. Weisberg, and B. Moss Vaccinia Virus Nonstructural Protein Encoded by the A11R Gene Is Required for Formation of the Virion Membrane J. Virol., June 1, 2005; 79(11): 6598 - 6609. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Aldaz-Carroll, J. C. Whitbeck, M. Ponce de Leon, H. Lou, L. Hirao, S. N. Isaacs, B. Moss, R. J. Eisenberg, and G. H. Cohen Epitope-Mapping Studies Define Two Major Neutralization Sites on the Vaccinia Virus Extracellular Enveloped Virus Glycoprotein B5R J. Virol., May 15, 2005; 79(10): 6260 - 6271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Fechter and G. G. Brownlee Recognition of mRNA cap structures by viral and cellular proteins J. Gen. Virol., May 1, 2005; 86(5): 1239 - 1249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. C. Carter, M. Law, M. Hollinshead, and G. L. Smith Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans J. Gen. Virol., May 1, 2005; 86(5): 1279 - 1290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Law, M. M. Putz, and G. L. Smith An investigation of the therapeutic value of vaccinia-immune IgG in a mouse pneumonia model J. Gen. Virol., April 1, 2005; 86(4): 991 - 1000. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Husain and B. Moss Role of Receptor-Mediated Endocytosis in the Formation of Vaccinia Virus Extracellular Enveloped Particles J. Virol., April 1, 2005; 79(7): 4080 - 4089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kidokoro, M. Tashiro, and H. Shida Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8 PNAS, March 15, 2005; 102(11): 4152 - 4157. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cyrklaff, C. Risco, J. J. Fernandez, M. V. Jimenez, M. Esteban, W. Baumeister, and J. L. Carrascosa Cryo-electron tomography of vaccinia virus PNAS, February 22, 2005; 102(8): 2772 - 2777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Komano, K. Miyauchi, Z. Matsuda, and N. Yamamoto Inhibiting the Arp2/3 Complex Limits Infection of Both Intracellular Mature Vaccinia Virus and Primate Lentiviruses Mol. Biol. Cell, December 1, 2004; 15(12): 5197 - 5207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Fogg, S. Lustig, J. C. Whitbeck, R. J. Eisenberg, G. H. Cohen, and B. Moss Protective Immunity to Vaccinia Virus Induced by Vaccination with Multiple Recombinant Outer Membrane Proteins of Intracellular and Extracellular Virions J. Virol., October 1, 2004; 78(19): 10230 - 10237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. P. Newsome, N. Scaplehorn, and M. Way Src Mediates a Switch from Microtubule- to Actin-Based Motility of Vaccinia Virus Science, October 1, 2004; 306(5693): 124 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Spehner, S. De Carlo, R. Drillien, F. Weiland, K. Mildner, D. Hanau, and H.-J. Rziha Appearance of the Bona Fide Spiral Tubule of Orf Virus Is Dependent on an Intact 10-Kilodalton Viral Protein J. Virol., August 1, 2004; 78(15): 8085 - 8093. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Law, M. Hollinshead, H.-J. Lee, and G. L. Smith Yaba-like disease virus protein Y144R, a member of the complement control protein family, is present on enveloped virions that are associated with virus-induced actin tails J. Gen. Virol., May 1, 2004; 85(5): 1279 - 1290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Cosma, S. Buhler, R. Nagaraj, C. Staib, A.-L. Hammarin, B. Wahren, F. D. Goebel, V. Erfle, and G. Sutter Neutralization Assay Using a Modified Vaccinia Virus Ankara Vector Expressing the Green Fluorescent Protein Is a High-Throughput Method To Monitor the Humoral Immune Response against Vaccinia Virus Clin. Vaccine Immunol., March 1, 2004; 11(2): 406 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Delhon, E. R. Tulman, C. L. Afonso, Z. Lu, A. de la Concha-Bermejillo, H. D. Lehmkuhl, M. E. Piccone, G. F. Kutish, and D. L. Rock Genomes of the Parapoxviruses Orf Virus and Bovine Papular Stomatitis Virus J. Virol., January 1, 2004; 78(1): 168 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Fonteneau, D. G. Kavanagh, M. Lirvall, C. Sanders, T. L. Cover, N. Bhardwaj, and M. Larsson Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells Blood, December 15, 2003; 102(13): 4448 - 4455. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Husain and B. Moss Evidence against an Essential Role of COPII-Mediated Cargo Transport to the Endoplasmic Reticulum-Golgi Intermediate Compartment in the Formation of the Primary Membrane of Vaccinia Virus J. Virol., November 1, 2003; 77(21): 11754 - 11766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Gallego-Gomez, C. Risco, D. Rodriguez, P. Cabezas, S. Guerra, J. L. Carrascosa, and M. Esteban Differences in Virus-Induced Cell Morphology and in Virus Maturation between MVA and Other Strains (WR, Ankara, and NYCBH) of Vaccinia Virus in Infected Human Cells J. Virol., October 1, 2003; 77(19): 10606 - 10622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. C. Carter, G. Rodger, B. J. Murphy, M. Law, O. Krauss, M. Hollinshead, and G. L. Smith Vaccinia virus cores are transported on microtubules J. Gen. Virol., September 1, 2003; 84(9): 2443 - 2458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pires de Miranda, P. C. Reading, D. C. Tscharke, B. J. Murphy, and G. L. Smith The vaccinia virus kelch-like protein C2L affects calcium-independent adhesion to the extracellular matrix and inflammation in a murine intradermal model J. Gen. Virol., September 1, 2003; 84(9): 2459 - 2471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Mercer and P. Traktman Investigation of Structural and Functional Motifs within the Vaccinia Virus A14 Phosphoprotein, an Essential Component of the Virion Membrane J. Virol., August 15, 2003; 77(16): 8857 - 8871. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Husain and B. Moss Intracellular Trafficking of a Palmitoylated Membrane-Associated Protein Component of Enveloped Vaccinia Virus J. Virol., August 15, 2003; 77(16): 9008 - 9019. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
